Jeito Capital Co-leads EUR 50 Million Financing in CatalYm, a Clinical-stage Biopharma Company Developing Novel Immunotherapies for Patients with Cancer

Paris, France, Nov. 22 (Korea Bizwire) - Jeito Capital (“Jeito”), a leading independent international private equity firm dedicated to healthcare and biopharma, announced today that it has co-led a EUR 50 million Series C financing round in CatalYm, a clinical-stage biopharmaceutical company developing novel immunotherapies to fight cancer. The oversubscribed financing was co-led by Brandon Capital with [...]